OLK

Olink Holding AB (publ) (OLK) | Rumor.io

Olink Holding AB (publ)

OLK

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about OLK?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.02	0% new	0% new	0% +0

Nov 15

Olink Holding AB's planned $3.1B sale to Thermo Fisher has been approved by the HSR, with the deal expected to close in mid-2024.
Olink reported Q3 2023 financial results, beating EPS estimates by $0.07 and revenue estimates by $0.92M.
The company reported a loss of $0.01 per share, which beat the consensus estimate of a loss of $0.08 per share.

Generated by AI

Sentiment

Of the messages about OLK that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	0%	0%	0% -95.24
Bearish	—	100%	100%	100% +95.24

Topics

Of the messages about OLK that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	100%	4.44%	4.44%	49.78%
Announcements	0%	0%	0%	0%
Controversies	0%	0%	0%	0%
Earnings	0%	0%	0%	0%
Macro	0%	95.56%	95.56%	50.22%
Technical Analysis	0%	0%	0%	0%

Oct 17

Thermo Fisher Scientific will acquire Olink Holding for $3.1 billion, or $26 per share, in cash, representing a 74% premium over the closing price on October 16, 2023.
The acquisition is expected to be accretive in the first full year of ownership, excluding certain costs, and is expected to be completed by mid-2024, subject to customary closing conditions and regulatory approvals.
Upon completion, Olink will become part of Thermo Fisher's Life Sciences Solutions segment, and is expected to grow mid-teens organically, with revenue of over $200 million in 2024.

Generated by AI

Community

Of the messages about OLK, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	0%
Newcomers	100%	100%	100%	100%

Regulars· Oct 17

$OLK was acquired by Thermo Fisher Scientific ($TMO) for $3.1 billion, or $26 per share, enhancing TMO's capabilities in the proteomics market.
The acquisition is expected to be completed by mid-2024, with TMO commencing a tender offer to acquire all of Olink's common shares and ADS.
The deal is expected to be accretive to TMO's business, with the company trading 21887% above average volume on the news, closing up 66.02%.

Newcomers· Oct 17

The acquisition of Olink Holding AB (publ) by Thermo Fisher Scientific for $3.1B is a significant deal, with Olink shareholders receiving $26 per share, representing a 74% premium.
The combination of Thermo Fisher Scientific and Olink is expected to bring together two leaders in their respective fields, with Olink's expertise in next-generation proteomics complementing Thermo Fisher's capabilities.
The deal values Olink at a significant premium to its previous capitalization, with the company's price increasing from $14 to $25 per share.

Generated by AI

Also Discussed

Investors talking about OLK also mention

#	Name	Attention
1	Nautilus Biotechnology, Inc.NAUT	0%-0.15
2	Quantum-Si Incorporated Class A Common StockQSI	0.02%+0.02
3	Thermo Fisher Scientific Inc.TMO	0%0
4	Seer, Inc. Class A Common StockSEER	0%0
5	Illumina Inc.ILMN	0%+0
6	AKYA - Akoya Biosciences, Inc.	——
7	OMIC - Singular Genomics Systems, Inc.	——
8	Azenta, Inc.AZTA	0%0
9	Foghorn Therapeutics Inc.FHTX	0%new
10	EXAI - Exscientia plc	——